Annual report pursuant to Section 13 and 15(d)

Convertible Bridge Loan (Detail textual)

v3.8.0.1
Convertible Bridge Loan (Detail textual)
1 Months Ended 12 Months Ended
Dec. 28, 2017
USD ($)
Day
$ / shares
Dec. 31, 2017
USD ($)
Short-term Debt [Line Items]    
Proceeds from Convertible debt issuance   $ 500,000
Convertible debt   $ 235,000
Bridge Loan | Secured Promissory Note and Security Agreement | Emerald Health Sciences Inc    
Short-term Debt [Line Items]    
Aggregate gross proceeds $ 900,000  
Proceeds from Convertible debt issuance 500,000  
Funding of remaining bridge loan $ 400,000  
Bridge loan interest rate 12.00%  
Bridge loan maturity date Jun. 30, 2018  
Initial conversion price | $ / shares $ 0.10  
Convertible debt $ 235,000  
Number of trading days as of financing close date | Day 1